Fresenius Medical Care names Korangy CEO as Fresenius Medical Care stock costs EUR 40.42
Published on 10/25/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership and trading at a glance
- Shervin Korangy became Fresenius Medical Care’s CEO on October 12, 2026.
- FMC stock trades in weekend trading at Lang & Schwarz at EUR 40.42 at 5:12 p.m. CEST on October 25, 2026, 0.10 percent below the Xetra close of October 23, 2026.
- Fresenius Medical Care reported 849,575 repurchased shares for the period ending October 16, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Fresenius Medical Care announced on October 7, 2026, that Shervin J. Korangy would become CEO and Chair of the Management Board effective October 12, 2026, succeeding Helen Giza, according to the company’s press release. Fresenius Medical Care stock costs EUR 40.42 in weekend trading at Lang & Schwarz on October 25, 2026, at 5:12 p.m. CEST, 0.10 percent below the Xetra close of EUR 40.46 on October 23, 2026.
Market context: Market report DAX.
The week in figures
The Xetra close for October 23, 2026, was EUR 40.46. The weekend indication at Lang & Schwarz was EUR 40.42 at 5:12 p.m. CEST on October 25, 2026.
Chronology of the week
Fresenius Medical Care reported that 849,575 shares were repurchased between October 12 and October 16, 2026, within the first tranche of its buyback. The company said the first tranche had acquired 10,935,840 shares in total. The disclosure was distributed by EQS News Service on October 19, 2026.
Dates of the coming week
The next Xetra session is scheduled for October 26, 2026. No forecast is implied by the weekend indication.
Weekend trading at Lang & Schwarz
The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CEST is shown by the continuously updated real-time quote of FMC stock.
